Cannabis as an Adjunct to or Substitute for Opiates in the Treatment of Chronic Pain
- 1 April 2012
- journal article
- research article
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 44 (2) , 125-133
Abstract
There is a growing body of evidence to support the use of medical cannabis as an adjunct to or substitute for prescription opiates in the treatment of chronic pain. When used in conjunction with opiates, cannabinoids lead to a greater cumulative relief of pain, resulting in a reduction in the use of opiates (and associated side-effects) by patients in a clinical setting. Additionally, cannabinoids can prevent the development of tolerance to and withdrawal from opiates, and can even rekindle opiate analgesia after a prior dosage has become ineffective. Novel research suggests that cannabis may be useful in the treatment of problematic substance use. These findings suggest that increasing safe access to medical cannabis may reduce the personal and social harms associated with addiction, particularly in relation to the growing problematic use of pharmaceutical opiates. Despite a lack of regulatory oversight by federal governments in North America, community-based medical cannabis dispensaries have proven successful at supplying patients with a safe source of cannabis within an environment conducive to healing, and may be reducing the problematic use of pharmaceutical opiates and other potentially harmful substances in their communities.Keywords
This publication has 41 references indexed in Scilit:
- Reassessment of the role of cannabinoids in the management of painCurrent Opinion in Anaesthesiology, 2007
- Barriers to access to medical cannabis for Canadians living with HIV/AIDSAIDS Care, 2007
- Cannabis in painful HIV-associated sensory neuropathyNeurology, 2007
- Cannabinoids in medicine: A review of their therapeutic potentialJournal of Ethnopharmacology, 2006
- Concurrent Cannabis Use During Treatment for Comorbid ADHD and Cocaine Dependence: Effects on OutcomeThe American Journal of Drug and Alcohol Abuse, 2006
- Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritisRheumatology, 2005
- Modulation of Oral Morphine Antinociceptive Tolerance and Naloxone-Precipitated Withdrawal Signs by Oral Δ9-TetrahydrocannabinolThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Antinociceptive Synergy between Δ9-Tetrahydrocannabinol and Opioids after Oral AdministrationThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Control of pain initiation by endogenous cannabinoidsNature, 1998
- A brief history of opiates, opioid peptides, and opioid receptors.Proceedings of the National Academy of Sciences, 1993